Orange Book product · Brand (NDA)

SUMAVEL DOSEPRO

SUMATRIPTAN SUCCINATE

Brand (NDA)NDA 022239DISCN ENDO OPERATIONS

Jul 15, 2009

Approved

Brand (NDA)

Application

Not listed

TE code

Listed patents

Approval
FDA approval date of this drug product.
Jul 15, 2009
17 yr 2 mo ago
Today
Patent 7901385 expires
Listed drug product patent expiration.
Jul 31, 2026
in 1 mo
Patent 7776007 expires
Listed drug product patent expiration.
Nov 22, 2026
in 5 mo

Active ingredient

SUMATRIPTAN SUCCINATE

Strength

EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML)

Dosage form

INJECTABLE

Route

SUBCUTANEOUS

TE code

Not listed

Application

NDA 022239

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

Active-ingredient family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
Patent	Expires	In	Type
7901385	Jul 31, 2026	in 1 mo	Product
7776007	Nov 22, 2026	in 5 mo	Product